Scoop has an Ethical Paywall
Why are we paying more for an easy-open cap on medication?
Why are we paying more for an easy-open cap on medication?
GSK are being asked questions
related to the price of their two products that are marketed
primarily to ease arthritis pain. Both products, Voltaren
Osteo Gel and Voltaren Emugel, contain exactly the same
ingredients, but it appears consumers are paying an
additional $9.66 to have a cap that is easier to open for
those with arthritis.
“Many consumers, including those with arthritis, struggle with opening items and while consumers are prepared to pay a premium for accessibility, the $9.66 in our view is exorbitant” said Arthritis New Zealand CEO Sandra Kirby.
Accessible packaging is an ongoing issue for people with arthritis in New Zealand. Arthritis New Zealand commends GSK for recognising the issue. We encourage other companies to invest in accessible packaging as a good business practice, but urge them to be realistic about the additional costs”.
Accessible packaging is an ongoing issue for people with arthritis in New Zealand. Arthritis New Zealand is working with the Packaging Council of New Zealand to encourage other companies to invest in accessible packaging as a good business practice.
Braden Currie: Sets Sights On The Ironman North American Championships In Texas
Whanganui Regional Museum: Historic Wedding Dress Unveiled, A Piece Of Marton’s Heritage
Donovan Ryan: Local Runner Takes Out Frontrunner Christchurch Marathon
University of Auckland: Tributes Flow For Much Loved Pacific Leader Melegalenu’u Ah Sam
NZEI: Ministry Of Education Cuts Will Disproportionately Affect Pasifika
Day One Hapai te Haeata: Call To Action For Young Filmmakers Against The Backdrop Of Funding Cuts